Triple therapy has been the gold standard for treatment of H pylori infection for several years. New research casts light on whether that standard should change.
The authors of a new study sought to determine whether H pylori eradication treatment reduces the risk of gastric cancer among those with a family history of gastric cancer in first-degree relatives.
Proton-pump inhibitors have been shown to be associated with worsening of gastric atrophy, especially in patients with Helicobacter pylori, but the risk of gastric cancer in these patients is unknown. ...
